Latest Sustainability In It News

Bhagwan Marine Limited reported a robust 5.3% revenue increase and a striking 125% surge in net profit for FY25, announcing its inaugural fully franked dividend.

TrivarX Limited reported a reduced net loss of $943K for FY25 alongside a $3.68 million equity raise, yet flagged material uncertainty over its ability to continue as a going concern.

Gumtree Australia Markets Limited reports a transformational FY25 marked by a $6.8 million Capital Markets division sale, a near doubling of EBITDA, and promising expansions in transactional services and partnerships.

Control Bionics Limited reported a 14.8% revenue increase to $6.14 million for FY2025 but also a 3.3% rise in net loss to $6.11 million, while pursuing a $2 million rights issue and expanding its investment portfolio.

Pentanet Limited has achieved its first full-year positive EBITDA of $1.4 million in FY25, driven by strong growth in its telecommunications and gaming segments, alongside strategic 5G network expansion and technology upgrades.

Pentanet has achieved its first full-year positive EBITDA of $1.4 million in FY25, driven by strong growth in 5G subscribers and a profitable gaming segment. The company’s strategic focus on capital-efficient 5G expansion and gaming platform optimisation signals a new phase of growth.

Gold Road Resources reports a robust half-year profit surge driven by higher gold prices and sales, while advancing a proposed acquisition by Gold Fields with a shareholder vote set for September.

WhiteHawk Limited reports an 8.6% revenue increase and a 26% reduction in net loss for H1 2025, alongside new US government contracts and a $1.56 million capital raise.

Sayona Mining delivered record lithium concentrate production and sales in FY25, driving revenue to $223 million despite a 16% drop in selling prices. The company also recorded a significant $271 million impairment on its North American Lithium assets amid weaker market conditions.

Noxopharm Limited reported a 36.5% increase in its annual loss to $4.88 million as it progressed preparations for its SOF-SKN™ clinical trial and secured $2.6 million through convertible notes. The biotech continues to invest heavily in its inflammation and oncology drug pipeline while managing liquidity and strategic partnerships.

Austal Limited has reported a remarkable 24% revenue increase and a 503% surge in net profit for FY2025, yet has chosen not to declare any dividends for the year.

Atlas Pearls reported increased pearl harvest and sales volumes for FY25, driving revenue growth to $44.3 million, though profits declined compared to the previous year. The company declared a fully franked final dividend, underscoring its solid financial footing.